Skip to Content
Merck

Cellular origin and pathophysiology of chronic lymphocytic leukemia.

The Journal of experimental medicine (2012-10-24)
Marc Seifert, Ludger Sellmann, Johannes Bloehdorn, Frederik Wein, Stephan Stilgenbauer, Jan Dürig, Ralf Küppers
ABSTRACT

The cellular origin of chronic lymphocytic leukemia (CLL) is still debated, although this information is critical to understanding its pathogenesis. Transcriptome analyses of CLL and the main normal B cell subsets from human blood and spleen revealed that immunoglobulin variable region (IgV) gene unmutated CLL derives from unmutated mature CD5(+) B cells and mutated CLL derives from a distinct, previously unrecognized CD5(+)CD27(+) post-germinal center B cell subset. Stereotyped V gene rearrangements are enriched among CD5(+) B cells, providing independent evidence for a CD5(+) B cell derivation of CLL. Notably, these CD5(+) B cell populations include oligoclonal expansions already found in young healthy adults, putatively representing an early phase in CLL development before the CLL precursor lesion monoclonal B cell lymphocytosis. Finally, we identified deregulated proteins, including EBF1 and KLF transcription factors, that were not detected in previous comparisons of CLL and conventional B cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-CD5 antibody produced in rabbit, affinity isolated antibody